Table 1 of
Brzović-Šarić, Mol Vis 2015; 21:649-664.
Table 1. Measured parameters and statistical differences within and between genders in non-diabetic patients with eye disorders (NDED) and proliferative diabetic retinopathy (PDR) patients.
Parameter | Group | Vitreous | Serum | ||
---|---|---|---|---|---|
Male | Female | Male | Female | ||
Mean ±S.E | Mean ±S.E | Mean ±S.E | Mean ±S.E | ||
VEGF (pg/l) | NDED | 176.3±34.8 | 213.5±50.5 | 18.9±2.7 | 29.0±6.2 |
PDR | 2048.9±408.4* | 1127.2±23.6* | 70.7±26.7* | 50.0±16.8 | |
AOPP(µM) | NDED | 44.0±12.3 | 43.9±25.6 | 231.9±19.6 | 250.3±18.8 |
PDR | 68.6±19.0 | 51.4±20.6 | 379.4±46.8* | 522.1±134.1* | |
LPO (µM) | NDED | 27.0±2.4 | 33.0±4.9 | 26.2±2.3 | 26.2±1.5 |
PDR | 145.8±6.3* | 135.6±10.9* | 168.1±6.9* | 159.0±8.7* | |
MDA (nmol/ml) | NDED | 55.8±10.9 | 58.1±12.5 | 31.9±3.1 | 40.4±6.4# |
PDR | 101.3±7.6* | 87.6±18.4* | 151.5±12.5* | 156.2±25.7* | |
SOD (U/ml) | NDED | 76.3±11.9 | 50.5±7.2 | 24.3±1.3 | 26.7±2.0 |
PDR | 30.5±2.5* | 28.5±3.8* | 158.8±23.5* | 122.1±13.7* | |
GSH (µmol/ml) | NDED | 41.1±1.1 | 38.9±0.4 | 90.5±6.32 | 80.2±5.4 |
PDR | 43.7±1.8 | 48.8±5.8 | 73.5±2.9* | 69.9±5.7* |